Related Experiment Video
Updated: Sep 27, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
[Changes of coagulation function in patients with adenomyosis]
1Department of Obstetrics and Gynecology, the First Clinical School of Medicine, Nanjing Medical University, Nanjing 210029, China.
Patients with adenomyosis exhibit hypercoagulability, a condition of increased blood clotting, during both menstrual and non-menstrual periods. This tendency may be linked to larger uterine volume, elevated cancer antigen 125 (CA125) levels, and anemia.
Area of Science:
- Gynecology
- Hematology
- Pathophysiology
Background:
- Adenomyosis is a gynecological condition characterized by the presence of endometrial tissue within the myometrium.
- Coagulation abnormalities have been anecdotally reported in adenomyosis patients, but comprehensive analysis is lacking.
Purpose of the Study:
- To investigate the coagulation state in patients with adenomyosis.
- To determine the clinical significance of these coagulation differences.
Main Methods:
- Retrospective analysis of clinical data from adenomyosis patients and controls.
- Comparison of coagulation indexes (fibrinogen, D-dimer, prothrombin time, etc.) during menstrual and non-menstrual periods.
- Correlation analysis of coagulation indexes with clinical parameters like CA125, CA19-9, and uterine volume.
Main Results:
- Patients with adenomyosis showed significantly higher fibrinogen and D-dimer levels during the menstrual period compared to the non-menstrual period.
- Elevated D-dimer and platelet counts were observed in adenomyosis patients compared to controls with cervical intraepithelial neoplasia grade III during the non-bleeding period.
- Coagulation indexes correlated significantly with CA125, CA19-9, and uterine volume, and were altered in anemic patients.
Conclusions:
- Adenomyosis patients exhibit a hypercoagulable state during both uterine bleeding and non-bleeding phases.
- This hypercoagulability may be associated with increased uterine volume, elevated serum CA125, and the presence of anemia.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
05:58Author Spotlight: In Vitro Endometrial Models to Study Epithelial-Stroma and Embryo Interactions
Published on: November 8, 2024
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...